Diaphragm rescue alone prevents heart dysfunction in dystrophic mice

Area of Science:

• Biomedical Research
• Genetics
• Cardiology

Background:

• Duchenne muscular dystrophy (DMD) is a severe X-linked disorder characterized by the absence of dystrophin.
• Current treatments for DMD are ineffective, with patients often succumbing to respiratory failure and cardiomyopathy.
• Cardiomyopathy is a major cause of mortality in DMD patients.

Purpose of the Study:

• To investigate if restoring diaphragm function can prevent cardiomyopathy in animal models of DMD.
• To determine if targeting respiratory muscles is sufficient to ameliorate cardiac dysfunction in DMD.

Main Methods:

• Utilized transgenic mdx mice with overexpressed utrophin in skeletal muscle and diaphragm.
• Administered peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) to restore dystrophin in skeletal muscle and diaphragm of mdx and double-knockout (dKO) mice.
• Assessed cardiac function using in vivo magnetic resonance imaging.

Main Results:

• Restoration of diaphragm function, through utrophin overexpression or dystrophin restoration via PPMO, normalized cardiac function in mdx mice.
• In dKO mice, PPMO treatment targeting diaphragm and skeletal muscle, but not the heart, also restored cardiac function to wild-type levels.
• No significant difference in cardiac function was observed between treating diaphragm alone versus diaphragm plus heart in dKO mice.

Conclusions:

• Restoration of diaphragm and respiratory muscle function is sufficient to prevent cardiomyopathy in dystrophic mice.
• This finding suggests a novel therapeutic strategy for DMD, focusing on respiratory muscles.
• Further research is warranted to explore the implications of this mechanism for direct cardiac treatment in DMD.